Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Merck : North American Businesses of Merck KGaA, Darmstadt, Germany Certified as 2017 Top Employer

share with twitter share with LinkedIn share with facebook
share via e-mail
02/16/2017 | 07:05pm CET

By a News Reporter-Staff News Editor at Drug Week -- - HYPERLINK "http://www.emdgroup.com/emd/index.html" nMerck KGaA, Darmstadt, Germany, a leading science and technology company which operates as EMD Serono, MilliporeSigma and EMD Performance Materials in the United States and Canada, announced that its North American businesses have been certified by the Top Employers Institute for exceptional employee offerings.

In addition to North America, Merck KGaA, Darmstadt, Germany has also achieved Top Employer status in the following regions where it operates businesses: Asia Pacific, Europe, Latin America and the Middle East.

"Throughout our nearly 350 year history, attracting the best and brightest talent in key regions such as North America, has been a fundamental part of what we do as a successful global company. Whether one is seeking a career in the research lab, or on the manufacturing floor, the opportunities are boundless at MilliporeSigma, EMD Serono and EMD Performance Materials in this region and this recognition only reaffirms the potential for people joining our organization," said Udit Batra, Member of the Executive Board, Merck KGaA, Darmstadt, Germany and CEO, MilliporeSigma (see also Pharmaceutical Companies).

"We are honored to receive this official certification as all of the businesses of Merck KGaA, Darmstadt, Germany are committed to empowering our talented employees to do their best work," said Gary Zieziula, President and Managing Director of EMD Serono and the spokesperson for the North American businesses for Merck KGaA, Darmstadt, Germany. "We are focused on continuing to foster a collaborative and creative environment so our employees can grow professionally and be inspired to further our mission of creating technologies that enhance the lives of people around the world."

The annual, international research undertaken by the Top Employers Institute recognizes leading employers around the world: those that provide excellent employee conditions, nurture and develop talent throughout all levels of the organization, and which strive to continuously optimize employment practices.

This recognition follows the Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany-MilliporeSigma and EMD Serono -which were named to The Boston Globe's annual "Top Places to Work" list in 2016. In addition, Merck KGaA, Darmstadt, Germany, ranked number 11 among the top 20 employers in the global biopharmaceutical industry by Science magazine, a leading peer-reviewed international scientific publication, also in 2016.

To achieve the Top Employers certification companies undergo a stringent research process in which they are assessed on criteria including talent strategy, workforce planning, leadership development and culture.

"Optimal employee conditions ensure that people can develop themselves personally and professionally," said David Plink, CEO of the Top Employers Institute. "Our comprehensive research concluded that Merck KGaA, Darmstadt, Germany?provides an outstanding employment environment, and offers a wide range of creative initiatives, from secondary benefits and working conditions, to performance-management programs that are well thought out and truly aligned with the culture of their company."

To learn more about the Top Employers Institute and the Top Employers Certification, visit: HYPERLINK "http://www.top-employers.com/" nwww.top-employers.com.

Keywords for this news article include: Pharmaceutical Companies, EMD Serono, Merck KGaA Darmstadt Germany.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

(c) 2017 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on MERCK KGAA
02/16 MERCK : North American Businesses of Merck KGaA, Darmstadt, Germany Certified as..
02/16 MERCK : New Hypertension Findings from Merck KGaA Described [Management of Hyper..
02/15 MERCK : to Supply Single-Use Systems to WuXi Biologics for Non-GMP Pilot Plant i..
02/09 Verastem Announces Dosing of First Patient in Combination Trial of Defactinib..
02/09 MERCK : North American Businesses of Merck KGaA, Darmstadt, Germany Certified as..
02/09 MERCK : Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with ..
02/07 MERCK : Jaffrey biochemical company to pay fine by EPA after alleged water pollu..
02/07 MERCK : Millipore settles lawsuit with EPA
02/07 MERCK : Jaffrey firm to pay penalty and comply with Clean Water Act
02/06 MERCK : Jaffrey, N.H. Facility to Upgrade Its Wastewater Treatment Systems Under..
More news
Sector news : Specialty & Advanced Pharmaceuticals
11:51aDJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
10:23aDJPURETECH HEALTH : Appoints Atul Pande as Chief Medical Officer
08:49aDJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
08:49aDJBAYER : CEO Still Upbeat on Deal -- WSJ
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
More sector news : Specialty & Advanced Pharmaceuticals
News from SeekingAlpha
02/03 Pfizer May Be Another IBM
01/23 Merck KGaA teams up with Domain Therapeutics in immuno-oncology
01/18 Astra's Mystic Mystery And Other Surprises In Store
01/12 Vertex And German Merck Find Their Perfect Fit
01/12 JPMorgan Day Three Roundup - Trump Reminds The Sector Who's In Charge
Financials (€)
Sales 2016 15 060 M
EBIT 2016 3 447 M
Net income 2016 1 795 M
Debt 2016 11 019 M
Yield 2016 1,19%
P/E ratio 2016 24,29
P/E ratio 2017 23,19
EV / Sales 2016 1,62x
EV / Sales 2017 1,44x
Capitalization 13 312 M
More Financials
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 109 €
Spread / Average Target 5,9%
Consensus details
EPS Revisions
More Estimates Revisions
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA3.88%14 053
ABBVIE INC-1.26%97 803
More Results